SEC Form 4 · accession 0001209191-16-144998
IQVIA HOLDINGS INC. · IQV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ari Bousbib
Officer — Chairman, CEO & Pres · Director
Period of report
Oct 3, 2016
Accepted (ET)
Oct 5, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001478242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 3, 2016 | A | 736,177 | — | A | 736,177 | D | |
| Common StockF1,F3,F4 | Oct 3, 2016 | A | 543,302 | — | A | 543,302 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F5 | $28.13 | Oct 3, 2016 | A | 192,000 | A | Sep 1, 2013 | Dec 1, 2020 | Common Stock | 192,000 | 192,000 | D |
| Employee Stock Option (Right to Buy)F6 | $21.36 | Oct 3, 2016 | A | 192,000 | A | Sep 1, 2015 | Dec 1, 2020 | Common Stock | 192,000 | 192,000 | D |
| Employee Stock Option (Right to Buy)F7 | $26.05 | Oct 3, 2016 | A | 460,800 | A | Sep 1, 2012 | Dec 1, 2020 | Common Stock | 460,800 | 460,800 | D |
| Employee Stock Option (Right to Buy)F8 | $15.11 | Oct 3, 2016 | A | 230,400 | A | Sep 1, 2013 | Dec 1, 2020 | Common Stock | 230,400 | 230,400 | D |
| Employee Stock Option (Right to Buy)F9 | $8.34 | Oct 3, 2016 | A | 460,800 | A | Sep 1, 2015 | Dec 1, 2020 | Common Stock | 460,800 | 460,800 | D |
| Stock Appreciation RightF11,F10 | $65.16 | Oct 3, 2016 | A | 82,847 | A | — | Feb 10, 2025 | Common Stock | 82,847 | 82,847 | D |
| Stock Appreciation RightF13,F12 | $59.90 | Oct 3, 2016 | A | 127,592 | A | — | Feb 2, 2026 | Common Stock | 127,592 | 127,592 | D |
Explanation of responses
- F1On May 3, 2016, Quintiles Transnational Holdings Inc. ("Quintiles") and IMS Health Holdings, Inc. ("IMS Health") entered into an Agreement and Plan of Merger pursuant to which, on October 3, 2016, IMS Health merged with and into Quintiles (the "Merger"), the separate existence of IMS Health ceased and Quintiles continued as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. ("Quintiles IMS Holdings"). The exchange ratio in the Merger was 0.3840 shares of Quintiles common stock for each share of IMS Health common stock. On the effective date of the Merger, the market value of Quintiles' common stock was $81.06 per share, and the market value of IMS Health's common stock was $31.34 per share.
- F10This stock appreciation right vests in four annual installments, with the first installment having vested on February 10, 2016 and the remaining three installments vesting on February 10, 2017, 2018 and 2019.
- F11Received in the Merger in exchange for a stock appreciation right to acquire 215,749 shares of IMS Health common stock for $25.02 per share.
- F12This stock appreciation right vests in four annual installments beginning on February 2, 2017.
- F13Received in the Merger in exchange for a stock appreciation right to acquire 332,272 shares of IMS Health common stock for $23.00 per share.
- F2Received in exchange for 1,917,133 shares of IMS Health common stock and restricted stock units in connection with the Merger.
- F3Received in exchange for 1,414,850 shares of IMS Health common stock in connection with the Merger.
- F4Shares held in Orohena Trust.
- F5Received in the Merger in exchange for a stock option to acquire 500,000 shares of IMS Health common stock for $10.80 per share.
- F6Received in the Merger in exchange for a stock option to acquire 500,000 shares of IMS Health common stock for $8.20 per share.
- F7Received in the Merger in exchange for a stock option to acquire 1,200,000 shares of IMS Health common stock for $10.00 per share.
- F8Received in the Merger in exchange for a stock option to acquire 600,000 shares of IMS Health common stock for $5.80 per share.
- F9Received in the Merger in exchange for a stock option to acquire 1,200,000 shares of IMS Health common stock for $3.20 per share.